{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:24:06Z","timestamp":1771338246532,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Catedra UAB-Gravida de Medicina i Immunologia Reproductiva"},{"name":"Synlab Group"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1136\/ard-2023-225042","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T18:20:23Z","timestamp":1700590823000},"page":"e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Correspondence on \u20182023 ACR\/EULAR antiphospholipid syndrome classification criteria\u2019"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-2693","authenticated-orcid":false,"given":"Francesc A","family":"Miro-Mur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Alijotas-Reig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Anunciacion-Llunell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Marques-Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1403-8419","authenticated-orcid":false,"given":"Enrique","family":"Esteve-Valverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Pardos-Gea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-225042_bib1","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225042_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR \/ EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-225042_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite Antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1136\/ard-2023-225042_bib4","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","article-title":"Anticardiolipin antibodies: detection by Radioimmunoassay and association with thrombosis in systemic lupus erythematosus","volume":"2","author":"Harris","year":"1983","journal-title":"Lancet"},{"key":"10.1136\/ard-2023-225042_bib5","first-page":"738","article-title":"Measurement of anti-Cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and Quantitation of results","volume":"62","author":"Loizou","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard-2023-225042_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ajcp\/94.4.476","article-title":"Special report. the second International anti-Cardiolipin standardization workshop\/the Kingston anti-phospholipid antibody study (KAPS) group","volume":"94","author":"Harris","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1136\/ard-2023-225042_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cca.2011.09.048","article-title":"Standards and reference materials for the Anticardiolipin and anti-\u03922Glycoprotein I assays: a report of recommendations from the APL task force at the 13th International Congress on Antiphospholipid antibodies","volume":"413","author":"Pierangeli","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1136\/ard-2023-225042_bib8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.15585","article-title":"Semiquantitative interpretation of Anticardiolipin and Anti\u03b22Glycoprotein I antibodies measured with various Analytical platforms: communication from the ISTH SSC subcommittee on lupus anticoagulant\/Antiphospholipid antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J Thromb Haemost"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724003728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724003728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-225042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:19:45Z","timestamp":1749806385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724003728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0003496724003728"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-225042","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correspondence on \u20182023 ACR\/EULAR antiphospholipid syndrome classification criteria\u2019","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-225042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-225054","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}